[1]
Nilay Danış, “Paritaprevir, ritonavir, ombitasvir, and dasabuvir treatment in renal transplant patients with hepatitis C virus infection”, Turkish Journal of Gastroenterology, vol. 30, no. 8, pp. 695–701, Aug. 2019.